4//SEC Filing
Recro Pharma, Inc. 4
Accession 0001123292-16-003027
CIK 0001588972operating
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:47 PM ET
Size
6.1 KB
Accession
0001123292-16-003027
Insider Transaction Report
Form 4
Mack Randall
Senior VP, Development
Transactions
- Exercise/Conversion
Common Stock
2016-12-01+6,100→ 11,654 total - Tax Payment
Common Stock
2016-12-01$6.48/sh−1,892$12,260→ 9,762 total
Footnotes (1)
- [F1]On December 1, 2016, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 6,100 performance-based restricted stock units, which were converted into 6,100 shares of common stock on a one-for-one basis.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0001588972
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:47 PM ET
- Size
- 6.1 KB